Medbravo Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $169K
Latest Deal Amount
  • Investors
  • 1

Medbravo General Information

Description

Developer of a networking platform that connects health care providers and research personnel to refer cancer patients for clinical trials. The company provides digital infrastructure to network hospitals, health professionals, and medical researchers to streamline referrals for the development of better cancer treatments worldwide.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Medical Records Systems
Other Industries
Social/Platform Software
Primary Office
  • 03100 Alicante
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medbravo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 25-Jul-2015 $169K 00000 Completed Startup
To view Medbravo’s complete valuation and funding history, request access »

Medbravo Executive Team (3)

Name Title Board Seat Contact Info
Andres Torrubia Co-Founder
Aurelia Bustos Moreno Co-Founder and Developer
To view Medbravo’s complete executive team members history, request access »

Medbravo Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medbravo Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
FICHe Accelerator/Incubator Minority 000 0000 000000 0
To view Medbravo’s complete investors history, request access »